Abstract

BackgroundCardiac myxomas (CMs) and thrombi are associated with high morbidity and mortality. These two conditions need totally different treatments. However, they are difficult to distinguish using naked eye. In clinical, misdiagnoses occur now and then. This study aimed to compare the characteristics of CMs and cardiac thrombi and investigate the value of a radiomics signature in distinguishing CMs from cardiac thrombi, based on cardiovascular contrast-enhanced computed tomography (CECT) images.MethodsA total of 109 patients who had CMs (n = 59) and cardiac thrombi (n = 50) were enrolled in this retrospective study from 2009 to 2019. First, the lesion characteristics of cardiovascular CECT images were documented and compared by two radiologists. Then all patients were randomly allotted to either a primary group or a validation group according to a 7:3 ratio. Univariate analysis and the least absolute shrinkage and selection operator were used to select robust features. The best radiomics signature was constructed and validated using multivariate logistic regression. An independent clinical model was created for comparison.ResultsThe best radiomics signature was developed using eight selected radiomics. The classification accuracies of the radiomics signature were 90.8% and 90.9%, and the area under the receiver operating characteristic curves were 0.969 and 0.926 in the training and testing cohorts, respectively. Cardiovascular CECT images showed that the two diseases had significant differences in location, surface, Hydrothorax, pericardial effusion and heart enlargement. The naked eye findings were used to create the clinical model. All metrics of the radiomics signature were higher than those of clinical model.ConclusionsCompared with clinical model, the radiomics signature based on cardiovascular CECT performed better in differentiating CMs and thrombi, suggesting that it could help improving the diagnostic efficiency.

Highlights

  • Cardiac tumors are rare, and three-quarters of these tumors are benign

  • Compared with clinical model, the radiomics signature based on cardiovascular contrast-enhanced computed tomography (CECT) performed bet‐ ter in differentiating Cardiac myxomas (CMs) and thrombi, suggesting that it could help improving the diagnostic efficiency

  • Full list of author information is available at the end of the article

Read more

Summary

Introduction

Cardiac myxomas (CMs) represent the vast majority of primary benign cardiac tumors [1, 2]. CM is a benign tumor that can lead to a lethal outcome and has a slim possibility of malignant transformation [3]. Because CMs can be lethal and have a slim chance of becoming malignant, patients with CMs need surgical therapy, while patients who have cardiac thrombi might only need anticoagulant therapy or cannot bear operative procedures because of the threat of thromboembolism or patients being poor situation. Cardiac myxomas (CMs) and thrombi are associated with high morbidity and mortality. These two conditions need totally different treatments. They are difficult to distinguish using naked eye. This study aimed to compare the characteristics of CMs and cardiac thrombi and investigate the value of a radiomics signature in distinguishing CMs from cardiac thrombi, based on cardiovascular contrast-enhanced computed tomography (CECT) images

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call